Canal Capital Management LLC Sells 213 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Canal Capital Management LLC lowered its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 8,330 shares of the medical equipment provider’s stock after selling 213 shares during the period. Canal Capital Management LLC’s holdings in Intuitive Surgical were worth $4,348,000 as of its most recent filing with the SEC.

A number of other large investors also recently added to or reduced their stakes in the business. Atala Financial Inc purchased a new stake in Intuitive Surgical during the 4th quarter valued at $25,000. Hurley Capital LLC bought a new stake in shares of Intuitive Surgical in the fourth quarter worth about $28,000. Berbice Capital Management LLC purchased a new position in Intuitive Surgical during the 4th quarter valued at about $26,000. BankPlus Trust Department purchased a new stake in Intuitive Surgical in the 4th quarter worth approximately $28,000. Finally, Summit Securities Group LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $30,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Robert Desantis sold 11,545 shares of the firm’s stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock valued at $17,691,621 in the last three months. Corporate insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently issued reports on ISRG shares. BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the company a “buy” rating in a research report on Monday, April 14th. Robert W. Baird reduced their price target on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 18th. CICC Research assumed coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price on the stock. Bernstein Bank upped their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. Finally, Barclays boosted their price target on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $611.81.

Intuitive Surgical Trading Up 0.3 %

Shares of ISRG stock opened at $482.74 on Monday. The stock has a market capitalization of $171.94 billion, a price-to-earnings ratio of 75.31, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 12-month low of $364.31 and a 12-month high of $616.00. The stock’s 50-day moving average price is $522.23 and its 200-day moving average price is $532.71.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.